2026
In Utero Exposure to the 1982 Tylenol Recall and Neurodevelopmental Outcomes
Verdict
UNSCIENTIFIC
Neither the paradigm nor the study inside it passes. The verdict is unscientific.
1·Study methodology · inside the paradigm
UNSCIENTIFIC
Does not follow the scientific method within Psychiatric Model.
2·Paradigm · Psychiatric Model
UNSCIENTIFIC
Fails the tests. The worse layer decides.
How the verdict is decided
The verdict grades both layers: the paradigm this study assumes, and how the study was carried out inside it. Both must be scientific for the whole thing to be scientific. A clean method inside an unscientific paradigm is unscientific. An unscientific method inside a better paradigm is unscientific. A split on either layer is mixed. The worse layer decides.
1·Study methodology
Did this study test its claim with methods that are independent, falsifiable, and non-circular?
UNSCIENTIFIC
This study claims that acetaminophen use in pregnancy does not meaningfully raise a child's risk of ADHD or autism, because children carried during the 1982 Tylenol recall were diagnosed at normal rates. All three tests fail.
Independently Verifiable
Fail
No mother's Tylenol use was recorded, so a birth date near the recall stands in for less Tylenol taken, and the outcome is a code a clinician entered after applying criteria.
Falsifiable
Fail
Every estimate pointed toward fewer diagnoses, and the Bonferroni adjustment turned each one into a non-result, so an effect could only appear already explained away.
Non-Circular
Fail
The expected trend is fitted from the same diagnosis codes it is then used to judge, and those codes exist only because clinicians applied the manual's criteria.
Why
They took two insurance billing files and sorted people by birth quarter or year. Children born in the months after the 1982 recall were labeled as exposed to less Tylenol in the womb, though no file recorded what any mother took. Years later, clinicians had entered ADHD and autism codes after applying their criteria. The authors drew a trend line through the codes from other birth dates and checked whether the recall cohorts sat off it. Every estimate pointed lower. None survived the Bonferroni adjustment, and they called that no effect. Nobody measured Tylenol taken in any pregnancy, and a short recall could not tell a drug that does nothing from mothers who never cut back.
2·Paradigm · Psychiatric Model
Does the framework this study assumes pass the three tests?
UNSCIENTIFIC
Independently Verifiable
Fail
A restless or withdrawn child can be seen, but the behavior list, the age cutoffs, and the claim that each label marks one condition come from the manual, not from watching.
Falsifiable
Fail
When counts rise the field says detection improved, and when they stay flat it can say the criteria were narrow, so no count can show the label groups children wrongly.
Non-Circular
Fail
Clinician committees wrote the criteria from cases they already called ADHD and autism, and the criteria are checked by whether other clinicians using them agree.
Why
The behavior is visible: a child who cannot sit still, a child who does not speak or look at others. Psychiatry adds the rest: the list of behaviors, how many are needed, by what age, the spectrum, and the claim that each label marks one condition. Rewrite the manual and the counts move while no child behaves differently. When rates rose after 1980, the field credited better detection or wider criteria, never a wrong category. The criteria were drawn up by clinicians from cases they already named, and validated by agreement between clinicians who use them. No result from outside that loop can show the label is the wrong way to group children.
From the study
Prevalence of ADHD and autism was not significantly different in birth cohorts exposed to the recall during gestation, when maternal acetaminophen use would have been reduced
-0.50 ADHD cases per 1,000 beneficiaries with in utero exposure to the recall, 95% CI -1.06 to 0.07, p=0.08, Bonferroni adjusted p=0.32
These findings are inconsistent with a clinically meaningful effect of maternal acetaminophen use on subsequent development of neurodevelopmental disorders.